Life Sciences based technologies require a company/institution independent mechanism to drive commercialization, when we consider the regulatory, financial and market requirements. Insight Bioventures has created a model with the help of regulatory structure, fund sources and industry bodies to help technologies achieve its potential.

Multi institutional approach is critical here. Insight demonstrated a ‘value creation’ model – a relay of value multiplication driven by value enhancers at various stages of core competence, as a result the product reaches the market faster with relatively low investment. Collective IP management is an integral part of this model, where innovation in IP management is a significant first step.

Second significant innovation associated with this model is the elimination of risk associated with investing in single technology. Funding sources shall invest simultaneously in multiple technologies and leverage their risk of failure. Cross market comparative advantage is another innovative factor of our ‘value creation’ model.

Third significant impact of ‘value creation; model is the access to best resources that shall fasten the path to reach market.

Insight’s partnership for driving your commercialization efforts is not just a value addition to your R&D, rather it is an alternate strategy to you R&D productivity.